Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19

Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis

“…COVID-19 is associated with an increase in the risk of thromboembolic complications, and the risk of myocardial infarction (MI) has been noted to be almost double within a week of a diagnosis of COVID-19. 3 ST-segment elevation MI (STEMI) patients with concurrent COVID-19 may not receive revascularization or other treatment in a timely manner due to concerns of infection transmission to healthcare workers and other patients. Patients with STEMI and COVID-19 have been observed to have significantly worse outcomes in some studies.…”

Temporal trends in cardiovascular care: Insights from the COVID-19 pandemic

“…Vaccination has shown promise in mitigating these trends, with improvement in the mortality of STEMI patients in a population in 2021 when vaccination was available when compared to the 2020 period when vaccination was not available. Furthermore, in this population those that were vaccinated had a lower risk of in-hospital mortality when compared to unvaccinated individuals in the same time period ( 104 ). In those with long COVID, cardiac symptoms such as chest pain, dyspnea and palpitations have been well documented.…”

COVID-19 Delays Presentation and Management of Acute Coronary Syndrome

“…Recognition of the above issues about diagnosis and management of ACS during the COVID-19 pandemic and critical analysis of various contributing factors has resulted in better awareness and hence more efficient clinical management planning. Recent data [20] showed that significant changes have occurred in the clinical characteristics, management strategies and outcomes of STEMI patients with COVID-19, mortality reduced by 25 % but still remains high for unvaccinated patients (p=0.009). Also, an increased use of invasive angiography for risk stratification and management in 2021 has been observed.…”